Correlation Between Veracyte and Immutep

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veracyte and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Immutep Ltd ADR, you can compare the effects of market volatilities on Veracyte and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Immutep.

Diversification Opportunities for Veracyte and Immutep

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Veracyte and Immutep is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of Veracyte i.e., Veracyte and Immutep go up and down completely randomly.

Pair Corralation between Veracyte and Immutep

Given the investment horizon of 90 days Veracyte is expected to generate 0.82 times more return on investment than Immutep. However, Veracyte is 1.23 times less risky than Immutep. It trades about 0.05 of its potential returns per unit of risk. Immutep Ltd ADR is currently generating about 0.02 per unit of risk. If you would invest  2,802  in Veracyte on September 12, 2024 and sell it today you would earn a total of  1,496  from holding Veracyte or generate 53.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.43%
ValuesDaily Returns

Veracyte  vs.  Immutep Ltd ADR

 Performance 
       Timeline  
Veracyte 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.
Immutep Ltd ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Veracyte and Immutep Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veracyte and Immutep

The main advantage of trading using opposite Veracyte and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.
The idea behind Veracyte and Immutep Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA